Author

Mateusz Wierdak

CONTROLLABLE DELIVERY OF CYTOPROTECTIVE CARBON MONOXIDE (CO) USING NOVEL CO-DELIVERING PRODRUGS COUNTERACTS BARRETT’S-LIKE METAPLASIA DEVELOPMENT
CONTROLLABLE DELIVERY OF CYTOPROTECTIVE CARBON MONOXIDE (CO) USING NOVEL CO-DELIVERING PRODRUGS COUNTERACTS BARRETT’S-LIKE METAPLASIA DEVELOPMENT

Mateusz Wierdak  et al.

HYDROGEN SULFIDE SIGNALING IN GERD-INDUCED MTOR-DEPENDENT PALIGENOSIS: IMPLICATION FOR BARRETT'S ESOPHAGUS PATHOGENESIS
HYDROGEN SULFIDE SIGNALING IN GERD-INDUCED MTOR-DEPENDENT PALIGENOSIS: IMPLICATION FOR BARRETT'S ESOPHAGUS PATHOGENESIS

Mateusz Wierdak  et al.

CONTRIBUTION OF HYDROGEN SULFIDE-PRODUCING CYSTATHIONINE-G-LYASE (CTH) IN THE DEVELOPMENT OF BARRETT'S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND SYSTEMIC INFLAMMATION
CONTRIBUTION OF HYDROGEN SULFIDE-PRODUCING CYSTATHIONINE-G-LYASE (CTH) IN THE DEVELOPMENT OF BARRETT'S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND SYSTEMIC INFLAMMATION

Mateusz Wierdak  et al.

INHIBITORY EFFECT OF PHARMACOLOGICALLY-DERIVED OR ENDOGENOUSLY PRODUCED HYDROGEN SULFIDE (H2S) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA THROUGH IL-1BETA/COX-2/PGE2 PATHWAY LOOP
INHIBITORY EFFECT OF PHARMACOLOGICALLY-DERIVED OR ENDOGENOUSLY PRODUCED HYDROGEN SULFIDE (H2S) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA THROUGH IL-1BETA/COX-2/PGE2 PATHWAY LOOP

Mateusz Wierdak  et al.

INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING
INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING

Mateusz Wierdak  et al.

CONTRIBUTION OF ENZYMATIC ACTIVITY OF HEME OXYGENASE (HMOX) AND ITS BYPRODUCT, CARBON MONOXIDE (CO) IN BARRETT'S METAPLASIA DEVELOPMENT
CONTRIBUTION OF ENZYMATIC ACTIVITY OF HEME OXYGENASE (HMOX) AND ITS BYPRODUCT, CARBON MONOXIDE (CO) IN BARRETT'S METAPLASIA DEVELOPMENT

Mateusz Wierdak  et al.

Item 1 - 6 / 6
1